About Immucura Team

This author has not yet filled in any details.
So far Immucura Team has created 171 blog entries.
iris.roth@immucura.com

Daniela

2022-04-24T06:46:05+00:00April 21st, 2022|

Daniela (UK) Urothelial carcinoma DCT + UCB This statement was given by a family member of the patient: “We thank you for all of your support during these trying times. We are [...]

Adoptive Immunotherapy for Pancreatic Cancer Using MUC1 Peptide-pulsed Dendritic Cells and Activated T Lymphocytes

2022-05-05T18:34:12+00:00April 11th, 2022|

Adoptive Immunotherapy for Pancreatic Cancer Using MUC1 Peptide-pulsed Dendritic Cells and Activated T Lymphocytes Overall Survival CONTACT US Summary This trial investigated the efficacy and safety of this DC-based [...]

Adoptive Immunotherapy for Pancreatic Cancer Using MUC1 Peptide-pulsed Dendritic Cells and Activated T Lymphocytes

2022-04-11T16:52:15+00:00April 11th, 2022|

Adoptive Immunotherapy for Pancreatic Cancer Using MUC1 Peptide-pulsed Dendritic Cells and Activated T Lymphocytes CT scans CONTACT US Summary This study aims to determine the clinical efficacy of immunotherapy [...]

Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival

2022-04-11T16:41:13+00:00April 11th, 2022|

Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival Overall Survival CONTACT US Summary This trial [...]

Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study

2022-04-11T16:24:18+00:00April 11th, 2022|

Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study Survival time CONTACT US Summary [...]

Long-Term Feasibility of 13.56 MHz Modulated Electro-Hyperthermia-Based Preoperative Thermoradiochemotherapy in Locally Advanced Rectal Cancer

2022-04-11T16:30:59+00:00April 11th, 2022|

Long-Term Feasibility of 13.56 MHz Modulated Electro-Hyperthermia-Based Preoperative Thermoradiochemotherapy in Locally Advanced Rectal Cancer Survival probability CONTACT US Summary This study evaluated the effect of 13.56 MHz modulated electro-hyperthermia [...]

Go to Top